BioCentury | Nov 20, 2020
Product Development
COVID vaccine updates for Pfizer-BioNTech, CureVac and Sinovac; plus Disbrow becomes permanent BARDA director
...plans to start a pivotal trial of the candidate before year-end.Disbrow becomes permanent BARDA directorThe U.S. Biomedical Advanced Research and Development Authority...